Galectin Therapeutics
GALT
#8252
Rank
S$0.20 B
Marketcap
$3.35
Share price
0.79%
Change (1 day)
21.88%
Change (1 year)

EPS for Galectin Therapeutics (GALT)

EPS in 2023 (TTM): -$0.90

According to Galectin Therapeutics's latest financial reports the company's current EPS (TTM) is -$0.87. In 2022 the company made an earnings per share (EPS) of -$0.85 a decrease over its 2021 EPS that were of -$0.68.

EPS history for Galectin Therapeutics from 2002 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$0.905.02%
2022-$0.8525%
2021-$0.6830%
2020-$0.53-6.98%
2019-$0.5713.16%
2018-$0.50-22.45%
2017-$0.64-35.53%
2016-$1.00-13.64%
2015-$1.1611.39%
2014-$1.04-39.69%
2013-$1.7281.94%
2012-$0.95-32.08%
2011-$1.397.07%
2010-$1.30-17.5%
2009-$1.58150%
2008-$0.63-68%
2007-$1.97127.27%
2006-$0.87-52.17%
2005-$1.81-20.69%
2004-$2.2952.63%
2003-$1.50-13.64%
2002-$1.74

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-$16.85 1,842.42%๐Ÿ‡บ๐Ÿ‡ธ USA
-$0.25-71.21%๐Ÿ‡บ๐Ÿ‡ธ USA